UK Biotechs Look Destined To Remain Bit Players

GW Pharma And Kymab Sold In Less Than A Month

snail
US biotechs leave the UK in their trail in the race for funding • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business